You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

seamless design

Showing 1 - 25 of 255
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Psychological Trial in Calgary (Mindfulness)

Not yet recruiting
  • Cancer
  • Psychological
  • Mindfulness
  • Calgary, Canada
    Tina Nguyen
Jul 19, 2022

Co-design ofSeamless Person-centered Intervention to Optimize

Not yet recruiting
  • Multimorbidity
    • (no location specified)
    Jul 7, 2022

    Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

    Not yet recruiting
    • Pulmonary Sarcoidosis
    • XTMAB-16 or Placebo
    • (no location specified)
    May 25, 2023

    Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

    Not yet recruiting
    • Primary IgA Nephropathy
    • SHR-2010 Injection
    • Placebo
    • (no location specified)
    Apr 27, 2023

    Stroke Trial in Bangkok (Seamless ADL training, Conventional ADL training)

    Completed
    Has Results
    • Stroke
    • Seamless ADL training
    • Conventional ADL training
    • Bangkok, Thailand
      Poungkaew Thitisakulchai
    Jul 16, 2021

    Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

    Not yet recruiting
    • Nonalcoholic Steatohepatitis (NASH)
    • ASC41 2 mg
    • +2 more
    • (no location specified)
    Jan 30, 2023

    Chikungunya Trial in Worldwide (BBV87 Chikungunya vaccine, Normal Saline)

    Recruiting
    • Chikungunya
    • BBV87 Chikungunya vaccine
    • Normal Saline
    • Barranquilla, Atlantico, Colombia
    • +6 more
    Mar 31, 2022

    Ischemic Stroke Trial (BIIB131, Placebo)

    Not yet recruiting
    • Ischemic Stroke
    • (no location specified)
    Feb 28, 2023

    Hookworm Infections Trial in Chake Chake (Emodepside, Albendazole 400mg)

    Not yet recruiting
    • Hookworm Infections
    • Chake Chake, Pemba, Tanzania
      Public Health Laboratory Ivo de Carneri
    Sep 9, 2022

    SCN2A-DEE, Epilepsy Trial in Memphis (PRAX-222 - Initial Dose, PRAX-222 - Initial Ascending Doses, PRAX-222 - Optional Ascending

    Recruiting
    • SCN2A-DEE
    • Epilepsy
    • PRAX-222 - Initial Dose
    • +4 more
    • Memphis, Tennessee
      Praxis Research Site
    Feb 10, 2023

    COVID-19 Infection Trial in Taichung (Allogeneic umbilical cord mesenchymal stem cells, Controlled normal saline)

    Active, not recruiting
    • COVID-19 Infection
    • Allogeneic umbilical cord mesenchymal stem cells
    • Controlled normal saline
    • Taichung, Non-US, Taiwan
      China Medical University Hospital
    Aug 11, 2022

    COVID-19 Trial in Santo André (Meplazumab for Injection, Sterile normal saline (0.9%))

    Recruiting
    • COVID-19
    • Meplazumab for Injection
    • Sterile normal saline (0.9%)
    • Santo André, Sao Paulo, Brazil
      Pesquisare Saúde
    Jun 2, 2022

    HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Aug 12, 2022

    Trichuris Trichiura; Infection, Hookworm Infections Trial in Chake Chake (Emodepside)

    Completed
    • Trichuris Trichiura; Infection
    • Hookworm Infections
    • Chake Chake, Tanzania
      Public Health Laboratory - Ivo de Carneri
    May 26, 2022

    Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

    Not yet recruiting
    • Pulmonary Tuberculosis
    • (no location specified)
    Oct 27, 2023

    Wet Age-related Macular Degeneration Trial in Chengdu (MW02, Lucentis)

    Recruiting
    • Wet Age-related Macular Degeneration
    • Chengdu, Si Chuan, China
      West China Hospital of Sichuan University
    Mar 17, 2022

    Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), Placebos)

    Recruiting
    • Myasthenia Gravis
    • HBM9161 Injection (680mg)
    • Placebos
    • Shanghai, Shanghai, China
      Huashan Hospital, Fudan University
    Dec 15, 2021

    Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

    Recruiting
    • Prostate Cancer
    • +4 more
    • PET-directed Local Therapy using Surgery
    • +10 more
    • Long Beach, California
    • +15 more
    Jul 29, 2022

    Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)

    Recruiting
    • Covid19
    • CST-2: EIDD-2801
    • +6 more
    • Cape Town, South Africa
    • +5 more
    Aug 9, 2022

    Diphtheria, Tetanus, Pertussis Trial (LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin

    Not yet recruiting
    • Diphtheria
    • +5 more
    • LBVD (Hexavalent vaccine)
    • Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
    • (no location specified)
    Jul 13, 2022

    Spinal Muscular Atrophy (SMA) Trial in Worldwide (RO7204239, Placebo, Risdiplam)

    Recruiting
    • Spinal Muscular Atrophy (SMA)
    • Boston, Massachusetts
    • +8 more
    Jan 18, 2023

    Thyroid Ophthalmopathy Trial in Shanghai (HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7)

    Recruiting
    • Thyroid Ophthalmopathy
    • HBM9161 680 mg qw by q2w from week 13
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai Jiaotong University S
    Feb 22, 2022

    Elderly Trial in Toulouse (soles, weighting machine, gripping force)

    Completed
    • Elderly
    • soles
    • +2 more
    • Toulouse, Midi-Pyrenes, France
      University Hospital, Toulouse
    Nov 6, 2020

    Coronavirus Infection, COVID-19 Trial in Saint Petersburg (Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or

    Recruiting
    • Coronavirus Infection
    • COVID-19
    • Low dose BCD-250 injection
    • +3 more
    • Saint Petersburg, Russian Federation
    • +1 more
    Sep 7, 2021

    Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib Trial in Shanghai (Neoadjuvant treatment)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • +3 more
    • Neoadjuvant treatment
    • Shanghai, Shanghai, China
      Zhongshan hospital
    Jul 5, 2021